Details of Bacterial Vaccine
This bacterial vaccine card gives comprehensive information about each vaccine.
| Detailed Information | |
|---|---|
| ID | 1209 |
| Name of the vaccine | IC43 |
| Microbe | Bacteria |
| Disease name | Pseudomonas infection |
| Name of bacteria | Pseudomonas aeruginosa |
| Type of vaccine | Recombinant |
| Nucleic acid content | DNA |
| Age | 18 to 80 years |
| Description of the vaccine | Recombinant Pseudomonas aeruginosa fusion protein. |
| Name of the manufacturer | Valneva Austria GmbH |
| Name of the manufacturing country | Austria, Belgium, Czech Republic, Germany, Hungary, Spain |
| Year of manufacture | 2015 |
| Clinical Phase status | Clinical - Phase 2, Phase 3 |
| Bacterial strain | Gram-negative bacteria. |
| Efficacy | NA |
| Vaccine formulation | NA |
| Dosage | 100 mcg two doses. |
| Mechanism of action | NA |
| Route of administration | Intramuscular |
| Indications | NA |
| Export | NA |
| Approval | NA |
| Adjuvant | NA |
| Repurposing | NA |
| Side effects of vaccine | NA |
| Post vaccination | NA |
| Dose type | Combination doses |
| Interspecies transfer | NA |
| PubMed identifier | NA |
| Clinical trial number | NCT01563263 |
| Reference | NA |
| Other name | NA |
| Additional Links | NA |